Expression of p16INK4a in Endometrioid Cancer Rat Model

被引:0
|
作者
Salinah [1 ]
Ekawuyung, Puspita [2 ]
Wiweko, Budi [3 ]
Kodariah, Ria [1 ]
Kusmardi [2 ]
机构
[1] Univ Indonesia, Fac Med, Magister Program Biomed Sci, Depok, Indonesia
[2] Univ Indonesia, Fac Med, Dept Anat Pathol, Depok, Indonesia
[3] Univ Indonesia, Fac Med, Dept Obstet & Gynecol, Depok, Indonesia
关键词
Animal Model; Endometrioid Cancer; p16INK4a; PROMOTER METHYLATION; HIGH-FREQUENCY; P16; CARCINOMAS; GENE; OVARIAN;
D O I
10.1166/asl.2018.12786
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Endometrioid cancer is a common gynecological malignancy in women. Endometrioid cancer model which resembles endometrioid cancer in human is needed to understand molecular carcinogenesis and the development of new therapies. Decreased expression of p16INK4a, a tumor suppressor gene, is found in endometrioid cancer and has prognostic value. The expression of this protein in animal models has been studied to evaluate its similarity with human endometrioid cancer. Methods: Fifteen paraffin blocks of rat consist of 5 normal uterine tissues, 5 atypical hyperplasia of uterine tissues, and 5 endometrioid cancer tissues were stained for immunohistochemistry. Expressions of p16INK4a were analyzed using IHC profiler Image-J software. Results: The expression score of p16INK4a increased significantly in the hyperplasia group compared with the normal group (p = 0.003) and significantly decreased in the endometrioid cancer group compared to the normal group (p = 0.01). Excessive expression of the tumor suppressor gene in the hyperplasia group is one of the cell's mechanisms to reduce the proliferation activity. Conclusion: Highest expression of p16INK4a was found in hyperplasia group and decreased to negative expression in endometrial cancer group. These patterns were similar to human endometrial cancer.
引用
收藏
页码:6584 / 6586
页数:3
相关论文
共 50 条
  • [1] P16INK4a expression in patients with penile cancer
    Martins, Vicenilma de Andrade
    Pinho, Jaqueline Diniz
    Lima Teixeira Junior, Antonio Augusto
    Nogueira, Leudivan Ribeiro
    Silva, Fabio Franca
    Maulen, Victor Eduardo
    Khayat, Andre Salim
    Rodrigues Calixto, Jose de Ribamar
    Costa, Herikson Araujo
    Zambelli Ramalho, Leandra Naira
    Barros Silva, Gyl Eanes
    PLOS ONE, 2018, 13 (10):
  • [2] p16INK4a Expression in Porokeratosis
    Uryu, Miki
    Furue, Masutaka
    ANNALS OF DERMATOLOGY, 2017, 29 (03) : 373 - 376
  • [3] Expression of p16INK4a prevents cancer and promotes aging in lymphocytes
    Liu, Yan
    Johnson, Soren M.
    Fedoriw, Yuri
    Rogers, Arlin B.
    Yuan, Hong
    Krishnamurthy, Janakiraman
    Sharpless, Norman E.
    BLOOD, 2011, 117 (12) : 3257 - 3267
  • [4] p16INK4a expression in precancerous lesions of the cervix
    Danilova, N. V.
    Malkov, P. G.
    HISTOPATHOLOGY, 2010, 57 : 107 - 107
  • [5] Loss of p16Ink4a
    Weitzman J.B.
    Genome Biology, 2 (1)
  • [6] Lack of mutation at p16INK4A gene but expression of aberrant p16INK4A RNA transcripts in human ovarian carcinoma
    Suh, SI
    Cho, JW
    Baek, WK
    Suh, MH
    Carson, DA
    CANCER LETTERS, 2000, 153 (1-2) : 175 - 182
  • [7] p16INK4a Expression and Breast Cancer Risk in Women with Atypical Hyperplasia
    Radisky, Derek C.
    Santisteban, Marta
    Berman, Hal K.
    Gauthier, Mona L.
    Frost, Marlene H.
    Reynolds, Carol A.
    Vierkant, Robert A.
    Pankratz, V. Shane
    Visscher, Daniel W.
    Tlsty, Thea D.
    Hartmann, Lynn C.
    CANCER PREVENTION RESEARCH, 2011, 4 (12) : 1953 - 1960
  • [9] p16INK4a expression, human papillomavirus, and survival in head and neck cancer
    Smith, Elaine M.
    Wang, Donghong
    Kim, Yoonsang
    Rubenstein, Linda M.
    Lee, John H.
    Haugen, Thomas H.
    Turek, Lubomir P.
    ORAL ONCOLOGY, 2008, 44 (02) : 133 - 142
  • [10] Promoter and histone methylation and p16INK4A gene expression in colon cancer
    Yoruker, Ebru Esin
    Mert, Ufuk
    Bugra, Dursun
    Yamaner, Sumer
    Dalay, Nejat
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (05) : 865 - 870